224 related articles for article (PubMed ID: 30832601)
21. MiR-100-3p and miR-877-3p regulate overproduction of IL-8 and IL-1β in mesangial cells activated by secretory IgA from IgA nephropathy patients.
Liang Y; Zhao G; Tang L; Zhang J; Li T; Liu Z
Exp Cell Res; 2016 Oct; 347(2):312-21. PubMed ID: 27542871
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the differential urinary protein profile in IgA nephropathy patients of Uygur ethnicity.
Guo Z; Wang Z; Lu C; Yang S; Sun H; Reziw ; Guo Y; Sun W; Yue H
BMC Nephrol; 2018 Dec; 19(1):358. PubMed ID: 30547763
[TBL] [Abstract][Full Text] [Related]
23. Urinary Erythrocyte-Derived miRNAs: Emerging Role in IgA Nephropathy.
Duan ZY; Cai GY; Li JJ; Bu R; Chen XM
Kidney Blood Press Res; 2017; 42(4):738-748. PubMed ID: 29050002
[TBL] [Abstract][Full Text] [Related]
24. Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy.
Neuhaus J; Bauer F; Fitzner C; Hilgers RD; Seibert F; Babel N; Doevelaar A; Eitner F; Floege J; Rauen T; Westhoff TH
Kidney Blood Press Res; 2018; 43(5):1563-1572. PubMed ID: 30347407
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-155-induced T lymphocyte subgroup drifting in IgA nephropathy.
Yang L; Zhang X; Peng W; Wei M; Qin W
Int Urol Nephrol; 2017 Feb; 49(2):353-361. PubMed ID: 27796698
[TBL] [Abstract][Full Text] [Related]
26. Identification of a uromodulin fragment for diagnosis of IgA nephropathy.
Wu J; Wang N; Wang J; Xie Y; Li Y; Liang T; Wang J; Yin Z; He K; Chen X
Rapid Commun Mass Spectrom; 2010 Jul; 24(14):1971-8. PubMed ID: 20552702
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy.
Yoon SY; Kim JS; Jung SW; Kim YG; Hwang HS; Moon JY; Lee SH; Seo JW; Seok J; Tae D; Jeong K
Sci Rep; 2023 Oct; 13(1):17201. PubMed ID: 37821628
[TBL] [Abstract][Full Text] [Related]
28. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy.
Duan ZY; Bu R; Liang S; Chen XZ; Zhang C; Zhang QY; Li JJ; Chen XM; Cai GY
Front Immunol; 2024; 15():1326026. PubMed ID: 38426107
[TBL] [Abstract][Full Text] [Related]
29. Noninvasive Urinary Monitoring of Progression in IgA Nephropathy.
Yang JYC; Sarwal RD; Fervenza FC; Sarwal MM; Lafayette RA
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510053
[TBL] [Abstract][Full Text] [Related]
30. Decreased Expression of Urinary Mammalian Target of Rapamycin mRNA Is Related to Chronic Renal Fibrosis in IgAN.
Cao Y; Wang Y; Liu Y; Zhu X; Zhang G; Wang S; Chen X; Liu D; Fu C
Dis Markers; 2019; 2019():2424751. PubMed ID: 31485275
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs in IgA nephropathy.
Yao X; Zhai Y; An H; Gao J; Chen Y; Zhang W; Zhao Z
Ren Fail; 2021 Dec; 43(1):1298-1310. PubMed ID: 34547971
[TBL] [Abstract][Full Text] [Related]
32. Exosomal miR-4639 and miR-210 in Plasma and Urine as Biomarkers in IgA Nephropathy.
Zhao S; Sun Y; Mao Q; Zhou C; Chen Y; Xue D
Nephron; 2022; 146(6):539-552. PubMed ID: 35381590
[TBL] [Abstract][Full Text] [Related]
33. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
Suzuki H; Allegri L; Suzuki Y; Hall S; Moldoveanu Z; Wyatt RJ; Novak J; Julian BA
Dis Markers; 2016; 2016():7806438. PubMed ID: 27647947
[TBL] [Abstract][Full Text] [Related]
34. A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity.
Han QX; Wang Y; Zhu HY; Zhang D; Gao J; Liu ZS; Cai GY; Chen XM
Chin Med J (Engl); 2019 Mar; 132(6):647-652. PubMed ID: 30855344
[TBL] [Abstract][Full Text] [Related]
35. Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy.
Feng Y; Lv LL; Wu WJ; Li ZL; Chen J; Ni HF; Zhou LT; Tang TT; Wang FM; Wang B; Chen PS; Crowley SD; Liu BC
Am J Pathol; 2018 Nov; 188(11):2542-2552. PubMed ID: 30142333
[TBL] [Abstract][Full Text] [Related]
36. Expressions of mRNA for innate immunity-associated functional molecules in urinary sediment in immunoglobulin A nephropathy.
Tsuruga K; Aizawa T; Watanabe S; Tsugawa K; Yoshida H; Imaizumi T; Ito E; Tanaka H
Nephrology (Carlton); 2015 Dec; 20(12):916-21. PubMed ID: 26058859
[TBL] [Abstract][Full Text] [Related]
37. Urinary CXCL1: a novel predictor of IgA nephropathy progression.
Zhao Y; Zhu L; Zhou T; Zhang Q; Shi S; Liu L; Lv J; Zhang H
PLoS One; 2015; 10(3):e0119033. PubMed ID: 25816025
[TBL] [Abstract][Full Text] [Related]
38. LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.
Surin B; Sachon E; Rougier JP; Steverlynck C; Garreau C; Lelongt B; Ronco P; Piedagnel R
Proteomics; 2013 Jan; 13(1):142-52. PubMed ID: 23161552
[TBL] [Abstract][Full Text] [Related]
39. Mapping novel immunogenic epitopes in IgA nephropathy.
Woo SH; Sigdel TK; Dinh VT; Vu MT; Sarwal MM; Lafayette RA
Clin J Am Soc Nephrol; 2015 Mar; 10(3):372-81. PubMed ID: 25542908
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of miRNA-21 prevents fibrogenic activation in podocytes and tubular cells in IgA nephropathy.
Bao H; Hu S; Zhang C; Shi S; Qin W; Zeng C; Zen K; Liu Z
Biochem Biophys Res Commun; 2014 Feb; 444(4):455-60. PubMed ID: 24468088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
